浙江省中药材生产现状及特色道地药材发展趋势

目的:分析2021年浙江省中药材种植面积、产量等数据,对浙江省中药资源种类多样性进行研究,为相关政策规划的制定提供参考依据。方法:采用Microsoft Excel 2010和Origin 2021软件,从全省中药材种植情况、县域中药材种植情况及道地药材等多个角度对2021年度浙江省中药材生产情况进行统计分析。结果:2021年浙江省中药材种植面积为5.74万hm^(2),其中多年生草本类、藤本类和乔木类中药材占比较高;“浙八味”生产总体保持稳定,新“浙八味”在种植面积、产量和产值上分别同比2020年增长3.60%、6.20%、4.11%。此外,黄精种植发展较快。结论:浙江省中药材产业整体呈现良好的发展态势,逐步形成了一批特色、优势道地品种,但部分道地药材种植出现一定萎缩,应综合考虑当地社会经济发展需求与临床用药需求,通过制定政策等形式给予引导和支持。

Production of Chinese Medicinal Materials and Development of Characteristic Genuine Medicinal Materials in Zhejiang Province

Objective To study the diversity of Chinese medicinal materials in Zhejiang province through the analysis of the cultivation area and production of the materials in the province in 2021, and to provide reference for the formulation of relevant policies and plans.Methods Microsoft Excel 2010 and Origin 2021 software were used to statistically analyse the production of Chinese herbal medicines in Zhejiang Province in the year 2021 from various perspectives, such as planting of Chinese herbal medicines in the province, planting of Chinese herbal medicines in counties, and genuine medicinal materials.Results In 2021, the cultivation area of Chinese medicinal materials in Zhejiang province was 57 400 hm², of which perennial herbs, vines and trees accounted for a high proportion. "Zhebawei" (the top eight Chinese medicinal materials in Zhejiang province) remained stable in production in general, while the new "Zhebawei" grew by 3.60%, 6.20% and 4.11% in terms of planting area, production and output value respectively, compared with 2020. In addition, Polygonati Rhizoma industry was booming.Conclusion The overall development of the Chinese medicinal material industry in Zhejiang Province has shown good momentum, and a number of characteristic genuine medicinal materials have been gradually formed. However, some genuine herbs has been shrinking in production area. Therefore, relevant policies should be formulated to guide the development of the industry based on the local social and economic development and clinical demands.